Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2017, Article ID 1402320, 4 pages
https://doi.org/10.1155/2017/1402320
Case Report

Multidrug Resistant Pseudomonas Mycotic Pseudoaneurysm following Cardiac Transplant Bridged by Ventricular Assistant Device

1Infection Management Unit, The Prince Charles Hospital, Brisbane, QLD 4032, Australia
2School of Medicine, University of Queensland, Brisbane, QLD, Australia
3Department of Pharmacy, The Prince Charles Hospital, Brisbane, QLD 4032, Australia

Correspondence should be addressed to C. Aye; moc.liamg@eya.wahc

Received 12 December 2016; Accepted 6 March 2017; Published 13 March 2017

Academic Editor: Daniela M. Cirillo

Copyright © 2017 C. Aye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. O. Taylor, R. B. Rehr, J. A. Thompson, G. Vetrovec, and J. L. Tatum, “Aortic pseudoaneurysm occurring after cardiac transplantation,” American Heart Journal, vol. 120, no. 5, pp. 1222–1225, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. R. D. Dowling, N. Baladi, M. Zenati et al., “Disruption of the aortic anastomosis after heart-lung transplantation,” The Annals of Thoracic Surgery, vol. 49, no. 1, pp. 118–122, 1990. View at Publisher · View at Google Scholar
  3. C. Knosalla, Y. Weng, H. Warnecke et al., “Mycotic aortic aneurysms after orthotopic heart transplantation: a three-case report and review of the literature,” Journal of Heart and Lung Transplantation, vol. 15, no. 8, pp. 827–839, 1996. View at Google Scholar · View at Scopus
  4. G. H. L. Tang, S. P. Pinney, S. R. Broumand, D. H. Adams, and A. C. Anyanwu, “Excellent outcomes with use of synthetic vascular grafts for treatment of mycotic aortic pseudoaneurysms after heart transplantation,” Annals of Thoracic Surgery, vol. 92, no. 6, pp. 2112–2117, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Omoto, K. Minami, T. Muramatsu, S. Kyo, and R. Körfer, “Pseudoaneurysm after heart transplantation with history of LVAD driveline infection,” Annals of Thoracic Surgery, vol. 72, no. 1, pp. 263–264, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Vigano', M. Rinaldi, A. M. D'Armini, C. Pederzolli, G. Minzioni, and A. M. Grande, “The spectrum of aortic complications after heart transplantation,” Annals of Thoracic Surgery, vol. 68, no. 1, pp. 105–111, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Yamane, H. Hirose, P. J. Mather, and S. C. Silvestry, “Mycotic pseudoaneurysm of the ascending aorta after heart transplantation: case report,” Transplantation Proceedings, vol. 43, no. 5, pp. 2055–2058, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Anthuber, B. M. Kemkes, E. Kreuzer et al., “Mediastinitis and mycotic aneurysm of the aorta: after orthotopic heart transplantation,” Texas Heart Institute Journal, vol. 18, no. 3, pp. 186–193, 1991. View at Google Scholar · View at Scopus
  9. F. Patanè, F. Sansone, A. Campanella, M. Attisani, and M. Rinaldi, “Mycotic pseudoaneurysm as aortic complication after heart transplantation,” Transplant International, vol. 22, no. 9, pp. 943–944, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Dulhunty, J. A. Roberts, J. S. Davis et al., “A multicenter randomized trial of continuous versus intermittent β-lactam infusion in severe sepsis,” American Journal of Respiratory and Critical Care Medicine, vol. 192, no. 11, pp. 1298–1305, 2015. View at Publisher · View at Google Scholar
  11. M. E. Falagas, G. S. Tansarli, K. Ikawa, and K. Z. Vardakas, “Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis,” Clinical Infectious Diseases, vol. 56, no. 2, pp. 272–282, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. E. J. Begg, M. L. Barclay, and S. B. Duffull, “A suggested approach to once-daily aminoglycoside dosing,” British Journal of Clinical Pharmacology, vol. 39, no. 6, pp. 605–609, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Wong, S. S. Kumar, G. G. Graham et al., “Comparing dose prediction software used to manage gentamicin dosing,” Internal Medicine Journal, vol. 43, no. 5, pp. 519–525, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Solomkin, E. Hershberger, B. Miller et al., “Ceftolozane/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI),” Clinical Infectious Diseases, vol. 60, no. 10, pp. 1462–1471, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. F. M. Wagenlehner, O. Umeh, J. Steenbergen, G. Yuan, and R. O. Darouiche, “Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI),” The Lancet, vol. 385, no. 9981, pp. 1949–1956, 2015. View at Publisher · View at Google Scholar · View at Scopus